Skip to main content
Transgene SA (EPA:TNG)
France flag France · Delayed Price · Currency is EUR
0.796
-0.024 (-2.93%)
Mar 9, 2026, 5:37 PM CET

Transgene Revenue

Transgene had revenue of 4.58M EUR in the half year ending June 30, 2025, a decrease of -3.86%. This brings the company's revenue in the last twelve months to 7.58M, up 16.65% year-over-year. In the year 2024, Transgene had annual revenue of 6.35M, down -19.58%.

Revenue (ttm)
7.58M
Revenue Growth
+16.65%
P/S Ratio
29.64
Revenue / Employee
51.53K
Employees
147
Market Cap
224.54M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20246.35M-1.55M-19.58%
Dec 31, 20237.90M-2.44M-23.63%
Dec 31, 202210.34M-6.90M-40.00%
Dec 31, 202117.24M7.67M80.08%
Dec 31, 20209.57M-3.72M-28.00%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cellectis 70.36M
Innate Pharma 12.64M
MaaT Pharma 3.92M
Adocia 12.88M
Sensorion 5.65M
Genfit 45.13M
ABIONYX Pharma 4.33M
OSE Immunotherapeutics 1.78M
Revenue Rankings

Transgene News

More News